Clinical trial
Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
NCT00114114 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00114114 |
|---|---|
| Title | Dose-Response of Gonadal Steroids and Bone Turnover in Older Men |
| Official title | Dose-Response of Gonadal Steroids and Bone Turnover in Older Men |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute on Aging (NIA) NIH Solvay Pharmaceuticals Industry AstraZeneca AbbVie |
| Status | Completed |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | Testosterone, Goserelin acetate |
| Enrollment | 177 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2017 |
| Completion | Nov 1, 2017 |
| First posted | Jun 14, 2005 |
| Last update posted | Oct 8, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: